Folinic Acid (Leucovorin): Clinical Indications and Dosing
Folinic acid (leucovorin) is primarily indicated for methotrexate rescue after high-dose therapy, treatment of methotrexate toxicity, and as a chemotherapeutic adjunct with 5-fluorouracil in colorectal cancer. It should not be confused with folic acid supplementation for routine methotrexate prophylaxis or pregnancy.
Primary Indications
1. Methotrexate Rescue After High-Dose Therapy
Standard leucovorin rescue begins at 15 mg (approximately 10 mg/m²) IV/IM/PO every 6 hours for 10 doses, starting 24 hours after the beginning of high-dose methotrexate infusion (12-15 grams/m² over 4 hours) 1, 2.
Dosing must be adjusted based on methotrexate levels and renal function:
Normal elimination (MTX ~10 micromolar at 24h, ~1 micromolar at 48h, <0.2 micromolar at 72h): Continue standard 15 mg every 6 hours for 60 hours 1
Delayed late elimination (MTX >0.2 micromolar at 72h, >0.05 micromolar at 96h): Continue 15 mg every 6 hours until MTX <0.05 micromolar 1
Delayed early elimination or acute renal injury (MTX ≥50 micromolar at 24h OR ≥5 micromolar at 48h OR 100% increase in creatinine): Escalate to 150 mg IV every 3 hours until MTX <1 micromolar, then 15 mg IV every 3 hours until MTX <0.05 micromolar 1
Continue hydration and urinary alkalinization (pH ≥7.0) throughout rescue 1. Monitor serum creatinine and methotrexate levels at least daily 1.
Critical timing consideration: Research suggests folinic acid rescue can be safely delayed to 30-36 hours after MTX (5-6 g/m²) without significant toxicity, but rescue at 42-48 hours resulted in considerable toxicity except with low MTX doses (1 g/m²) 3. The optimal rescue dose is 105 mg/m² starting no later than 36 hours from MTX initiation 3.
2. Methotrexate Toxicity/Overdose
**For inadvertent overdose or impaired elimination, begin leucovorin 10 mg/m² IV/IM/PO every 6 hours as soon as possible (ideally within 24 hours) until serum MTX <10⁻⁸ M** 1. If 24-hour creatinine increases 50% over baseline OR 24-hour MTX >5 × 10⁻⁶ M OR 48-hour MTX >9 × 10⁻⁷ M, increase to 100 mg/m² IV every 3 hours until MTX <10⁻⁸ M 1.
High-dose leucovorin (0.24-8 g/day) can be used as sole therapy for severe MTX toxicity without requiring hemodialysis or hemoperfusion, even with MTX levels up to 940 micromolar at 24 hours 4. In this cohort, all patients recovered despite significant neutropenia (8/13 patients) and thrombocytopenia (7/13 patients) 4.
For severe low-dose methotrexate toxicity (WBC ≤2 × 10⁹/L or platelets ≤50 × 10⁹/L), both 15 mg and 25 mg IV leucovorin every 6 hours appear equally effective, with no significant difference in 30-day mortality (42% vs 47%) or hematological recovery 5. The standard 15 mg dose is therefore reasonable 5.
When hematologic toxicity occurs with low-dose methotrexate, folinic acid at 10 mg/m² should be administered immediately, with subsequent doses every 6 hours 6. The effectiveness decreases as the interval between methotrexate administration and folinic acid treatment increases 6.
3. Chemotherapeutic Adjunct (Advanced Colorectal Cancer)
Two FDA-approved regimens with 5-fluorouracil 1:
- Regimen 1: Leucovorin 200 mg/m² IV over ≥3 minutes, followed by 5-FU 370 mg/m² IV daily × 5 days, repeated every 28 days
- Regimen 2: Leucovorin 20 mg/m² IV, followed by 5-FU 425 mg/m² IV daily × 5 days, repeated every 28-35 days
Adjust 5-FU dose based on toxicity (reduce 20% for moderate toxicity, 30% for severe); leucovorin doses remain unchanged 1.
4. Gestational Trophoblastic Neoplasia
For low-risk GTN, methotrexate 50 mg IM on days 1,3,5,7 with folinic acid 15 mg PO 30 hours after each MTX dose (days 2,4,6,8) is the standard regimen 7. Recent evidence shows folic acid 20 mg/day on days 2,4,6,8 achieves similar treatment success (83.3% vs 84.8%) and toxicity rates compared to folinic acid 8, though folinic acid remains the established standard 7.
Folinic Acid vs. Folic Acid: Critical Distinctions
These are NOT interchangeable for methotrexate rescue. Folinic acid (leucovorin) is the reduced, active form that bypasses methotrexate's mechanism of action and serves as the antidote for methotrexate toxicity 6.
For Routine Methotrexate Prophylaxis (Rheumatoid Arthritis, Psoriasis)
Folic acid ≥5 mg/week is strongly recommended (Grade A) to reduce gastrointestinal and hepatic toxicity without compromising efficacy 9. Folinic acid ≤5 mg/week is equally effective but more expensive 10, 9.
Key evidence: Folic acid supplementation reduces GI side effects (OR 0.42), hepatotoxicity (OR 0.17), and drug discontinuation (OR 0.39) 9. However, folinic acid >5 mg/week may reduce methotrexate efficacy (increased tender/swollen joints, OR 6.27 and 5.3 respectively) 9.
Practical approach: Use folic acid 1-5 mg daily except on methotrexate dosing day 10, 11. Both folic and folinic acid reduce hepatic abnormalities and GI effects, but evidence for hematologic protection is uncertain 10.
Pregnancy Considerations
Methotrexate is absolutely contraindicated during pregnancy (teratogenic at all gestational ages) and must be discontinued ≥3 months before planned conception for both men and women 9, 12.
For pregnancy supplementation, standard folic acid 0.4-5 mg daily is recommended, not folinic acid 12, 13. Recent evidence suggests 5-methyltetrahydrofolate (5-MTHF) may be an alternative that reduces unmetabolized folic acid while maintaining folate status 14, 15, though this is not folinic acid/leucovorin.
Megaloblastic Anemia Due to Folate Deficiency
Leucovorin up to 1 mg daily is indicated 1. Doses >1 mg/day show no additional efficacy, with excess folate lost in urine 1.
Critical Warnings
- Never administer leucovorin intrathecally 1, 2
- Do not use leucovorin for pernicious anemia or vitamin B12 deficiency - it may mask hematologic manifestations while allowing neurologic damage to progress 1
- Large doses of folinic acid may reduce methotrexate efficacy when used prophylactically 10
- Leucovorin contains no preservative; reconstitute immediately before use 1
Common Pitfalls
- Confusing folic acid with folinic acid: Use folic acid for routine prophylaxis, folinic acid (leucovorin) for rescue/toxicity
- Inadequate dose escalation: Must increase to 150 mg IV q3h for delayed early elimination or renal injury 1
- Delayed rescue initiation: Begin within 24 hours of high-dose MTX; effectiveness decreases with time 6, 1
- Insufficient monitoring: Check MTX levels and creatinine at least daily during rescue 1
- Premature discontinuation: Continue until MTX <0.05 micromolar, which may take 7-17 days in severe toxicity 4